Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay
Journal of Clinical Microbiology · 2025
DOI: 10.1128/jcm.02071-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von Shi Song und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of …. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B virus, Hepatitis B, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
The significance of occult hepatitis B virus (HBV) infection (OBI) has been increasingly recognized while the underlying mechanisms remain incompletely understood. This study aimed to identify high-frequency OBI-related mutations in HBV surface antigen (HBsAg)-negative samples tested by the ultrasensitive Lumipulse G HBsAg-Quant assay. OBI samples were collected from 32 blood establishments across 14 provinces in China. Lumipulse G HBsAg-Quant assay was performed for the re-testing and reclassification of OBI. Mutations in genotypes B (GTB) and C (GTC) were analyzed to identify high-frequency single and combined mutations. Additionally, the efficacy of commercial reagents commonly employed in clinical diagnostics for detecting mutant HBsAg was evaluated. Western Blot was used for the confirmation of extracellular HBsAg as well as the detection of intracellular HBsAg. Hydrophilicity analysis and transmembrane distribution prediction of HBsAg were utilized for further validation. Single mutations at 17 sites and 9 combined mutations in GTB indicated a significantly elevated mutation frequency. In GTC, there were single mutations at 16 sites and 9 combined mutations. Several commercial reagents commonly demonstrated limited capacity toward mutant HBsAg with T123A/P, K141C, and P142R/I/K/L (GTB) and S114A/P (GTC). The findings indicated that mutations including T123A/C/K/S, S132G/Y, P142L/R/S/T, T143M, D144G, G145A, K160R+V168A, I4T+V168A, M103I+K122R, and M103I+Q181R (GTB), along with Q101H, M103I, R160K+C221Y (GTC), were associated with reduced levels of HBsAg both extracellularly and intracellularly. Additionally, K160R (GTB) and E2G (GTC) were associated with intracellular aggregation. This study elucidates the mutations associated with decreased extracellular HBsAg with ultrasensitive HBsAg assay, providing insight for further investigation into the mechanisms of OBI. IMPORTANCE The sensitivity of HBsAg detection reagents directly impacts the identification of occult hepatitis B virus (HBV) infection (OBI). This study aims to identify high-frequency OBI-related mutations in HBV surface antigen (HBsAg)-negative samples evaluated using a Fujirebio-Lumipulse ultrasensitive HBsAg assay and to investigate the implications of these mutations on the antigenicity of HBsAg, the detection capacities of various HBsAg assays, and the effects on intracellular and extracellular levels of HBsAg. Generally, our study offers a new perspective on OBI-related mutations by ultrasensitive HBsAg assay and lays the groundwork for further research on the OBI mechanism and the enhancement of HBsAg detection reagents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China.
- Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, China.
- National Center for Clinical Laboratories, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Shi Song, Qian Su, Le Chang, Lunan Wang
Förderung
- National High Level Hospital Clinical Research Funding
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Song, S., Su, Q., Yan, Y., Ji, H., Sun, H., Feng, K., Nuermaimaiti, A., Halemubieke, S., Mei, L., Liu, X., Lu, Z., Chang, L., & Wang, L. (2025). Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.02071-24
Vancouver
Song S, Su Q, Yan Y, Ji H, Sun H, Feng K, et al. Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.02071-24
BibTeX
@article{Song2025,
author = {Song, Shi and Su, Qian and Yan, Ying and Ji, Huimin and Sun, Huizhen and Feng, Kaihao and Nuermaimaiti, Abudulimutailipu and Halemubieke, Shana and Mei, Ling and Liu, Xinru and Lu, Zhuoqun and Chang, Le and Wang, Lunan},
title = {Identification and characteristics of mutations promoting occult HBV infection by ultrasensitive HBsAg assay},
journal = {Journal of Clinical Microbiology},
year = {2025},
doi = {10.1128/jcm.02071-24}
}
EUVIMED